NYSE:MNK
Delisted
Mallinckrodt plc Stock News
$0.116
+0 (+0%)
At Close: Jul 20, 2022
Centerbridge Partners, L.P. Buys iShares iBoxx $ Investment Grade Corporate Bond, Surgery ...
12:00am, Friday, 15'th May 2020Mallinckrodt (MNK) Q1 Earnings Beat Estimates, Sales Miss
03:34pm, Wednesday, 06'th May 2020
Mallinckrodt (MNK) declines on sales miss in the first quarter and a challenging outlook for the remainder of the year despite reporting an earnings beat.
SVB Leerink Maintains Market Perform on Mallinckrodt, Raises Price Target of $3
03:17pm, Wednesday, 06'th May 2020Edited Transcript of MNK earnings conference call or presentation 5-May-20 12:30pm GMT
12:29pm, Wednesday, 06'th May 2020
Q1 2020 Mallinckrodt Plc Earnings Call
Mallinckrodt (MNK) Q1 2020 Earnings Call Transcript
02:01am, Wednesday, 06'th May 2020
Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Mallinckrodt earnings conference call. Joining me this morning are Mark Trudeau, CEO; Steven Romano, our chief scientific o
Why Mallinckrodt Stock Tumbled Today
08:49pm, Tuesday, 05'th May 2020
Investors were disappointed by the company's Q1 results and the prospects of continued challenges from the COVID-19 pandemic.
Mallinckrodt (MNK) Q1 Earnings Surpass Estimates
01:55pm, Tuesday, 05'th May 2020
Mallinckrodt (MNK) delivered earnings and revenue surprises of 16.31% and -2.15%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Mallinckrodt shares are trading lower the company reported worse-than-expected Q1 sales.
12:38pm, Tuesday, 05'th May 2020Recap: Mallinckrodt Q1 Earnings
11:11am, Tuesday, 05'th May 2020
Shares of Mallinckrodt (NYSE:MNK) were unchanged in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share decreased 15.46% over the past year to $1.64, which be
Mallinckrodt Q1 Adj. EPS $1.640 Beats $1.480 Estimate, Sales $665.800M Miss $693.310M Estimate
10:46am, Tuesday, 05'th May 2020Mallinckrodt plc Reports Earnings for the First Quarter 2020 and Highlights Pipeline Progress
10:45am, Tuesday, 05'th May 2020
First quarter net sales of $665.8 million, with diluted loss per share of $0.60, with results impacted in part by competitive and payer pressures in certain products and a decline in demand due to COV
Mallinckrodt's INOmax Study Ended Early Due to Achievement of its Primary Goal
10:47am, Monday, 04'th May 2020
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that its observational registry comparing the safety and effectiveness of INOmax® (nitric oxide) gas, for inhalation,
